Concourse Financial Group Securities, Inc. Moderna, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 601 shares of MRNA stock, worth $19,183. This represents 0.0% of its overall portfolio holdings.

Number of Shares

601

Previous 650 7.54%

Holding current value

$19,183

Previous $43,000 44.19%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$36.85 - $63.93 $1,805 - $3,132	-49 Reduced 7.54%	601 $24,000
Q3 2024 Oct 10, 2024	SELL	$63.64 - $125.14 $9,609 - $18,896	-151 Reduced 18.85%	650 $43,000
Q2 2024 Jul 23, 2024	BUY	$101.21 - $166.61 $202 - $333	2 Added 0.25%	801 $95,000
Q1 2024 Apr 30, 2024	BUY	$85.37 - $115.44 $2,134 - $2,886	25 Added 3.23%	799 $85,000
Q4 2023 Feb 07, 2024	SELL	$69.51 - $104.43 $1,390 - $2,088	-20 Reduced 2.52%	774 $76,000
Q3 2023 Oct 25, 2023	SELL	$96.41 - $126.61 $13,111 - $17,218	-136 Reduced 14.62%	794 $82,000
Q2 2023 Aug 10, 2023	BUY	$118.5 - $160.53 $20,856 - $28,253	176 Added 23.34%	930 $112,000
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $8,953 - $13,003	-66 Reduced 8.05%	754 $115,000
Q4 2022 Jan 30, 2023	SELL	$118.38 - $210.04 $1,065 - $1,890	-9 Reduced 1.09%	820 $0
Q3 2022 Nov 15, 2022	BUY	$118.07 - $194.18 $39,435 - $64,856	334 Added 67.47%	829 $98,000
Q2 2022 Aug 09, 2022	SELL	$117.13 - $176.59 $6,090 - $9,182	-52 Reduced 9.51%	495 $71,000
Q1 2022 May 09, 2022	SELL	$126.46 - $235.05 $57,412 - $106,712	-454 Reduced 45.35%	547 $94,000
Q4 2021 Feb 07, 2022	SELL	$225.82 - $368.51 $13,097 - $21,373	-58 Reduced 5.48%	1,001 $254,000
Q3 2021 Nov 09, 2021	SELL	$221.9 - $484.47 $51,702 - $112,881	-233 Reduced 18.03%	1,059 $408,000
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $17,667 - $31,957	136 Added 11.76%	1,292 $303,000
Q1 2021 May 13, 2021	BUY	$109.18 - $185.98 $2,620 - $4,463	24 Added 2.12%	1,156 $151,000
Q4 2020 Feb 02, 2021	BUY	$65.74 - $169.86 $26,098 - $67,434	397 Added 54.01%	1,132 $118,000
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $7,770 - $13,563	143 Added 24.16%	735 $52,000
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $17,564 - $47,360	592 New	592 $38,000
Q1 2020 May 13, 2020	BUY	$17.78 - $31.58 $0 - $0	0 New	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$12.26 - $18.07 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$13.7 - $28.34 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$14.45 - $23.7 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$13.52 - $18.8 $0 - $0	0 New	0 $0

Others Institutions Holding MRNA

# of Institutions

899

Shares Held

239M

Call Options Held

12.1M

Put Options Held

20.8M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $12.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account

Concourse Financial Group Securities, Inc. Moderna, Inc. Transaction History